Latest News

Study provides new analysis of isotretinoin and risk for adverse neuropsychiatric outcomes

Publish date: May 5, 2022

 

FROM THE BRITISH JOURNAL OF DERMATOLOGY

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Study highlights impact of acne in adult women on quality of life, mental health
MDedge Internal Medicine
FDA OKs iPLEDGE change for gender-neutral language
MDedge Internal Medicine
Cannabinoids being studied for a variety of dermatologic conditions
MDedge Internal Medicine
Topical options for acne patients continue to expand
MDedge Internal Medicine
International panel backs energy-based devices as first-line treatment of acne scars
MDedge Internal Medicine
Dermatologists take to TikTok to share their own ‘hacks’
MDedge Internal Medicine
iPLEDGE rollout described as a failure, chaotic, and a disaster
MDedge Internal Medicine
iPLEDGE rollout: As frustration mounts, FDA agrees to help solve issues
MDedge Internal Medicine
More than a month after launch, iPLEDGE glitches persist
MDedge Internal Medicine
Spironolactone not linked to increased cancer risk in systematic review and meta-analysis
MDedge Internal Medicine